Open Outbreak

Nipah virus infection

Also known as: Nipah, NiV, henipavirus, Henipavirus nipahense

Nipah virus infection is a disease that can pass from animals to people and between people through close contact. Fruit bats, also called flying foxes, are its natural hosts. People can become infected through infected animals or food contaminated by bats, including raw date palm sap. Infection can cause fever, breathing problems and encephalitis, meaning inflammation of the brain. Some infections cause no symptoms, but severe illness can progress rapidly. WHO reports that 40–75% of identified cases die, with the proportion varying between outbreaks and health-care settings. There is no licensed Nipah-specific medicine or vaccine in the WHO update dated 2026-06-25. Intensive supportive care is recommended for severe illness. Reported outbreaks have occurred in several Asian countries, with recurring events in Bangladesh and India. Prevention focuses on reducing exposure to contaminated food and infected animals, recognizing cases early, and preventing spread during close contact and care. The latest WHO notice retrieved for this page concerns a case in Kerala, India; it is not a complete worldwide status report for 2026-11-22.

Key facts

TransmissionContact with infected animals; food or fruit products contaminated by infected bats; close contact with an infected person.
IncubationWHO's 2026-06-25 notice gives 3–14 days, with rare reports of up to 45 days.
Case fatalityWHO reports 40–75% across outbreaks, varying with early detection and clinical management. Separate treated and untreated estimates are unknown from the retrieved sources.
Reproduction numberunknown
VaccineNo licensed Nipah vaccine according to WHO's 2026-06-25 notice; development is a WHO research priority.
TreatmentIntensive supportive care for respiratory and neurological complications. No licensed Nipah-specific medicine according to WHO's 2026-06-25 notice.
ReservoirFruit bats or flying foxes of the genus Pteropus.
Endemic regionsRecurring human outbreaks in Bangladesh and parts of India. Outbreaks have also been reported in Malaysia, Singapore and the Philippines; the natural bat hosts have a wider geographic distribution.

Transmission

Nipah can pass from animals to people, through contaminated food, and between people through close contact. Fruit bats are the natural hosts. Their saliva, urine or other waste can contaminate fruit and fruit products, including raw date palm sap. Infected animals, including pigs, can also be a source of infection. Person-to-person spread is established: an investigation in Bangladesh described illness among people who had close contact with other cases. Family members and health-care workers therefore need protection when caring for someone with suspected infection. Finding the original animal or food exposure matters, but so does tracing contacts who may have been exposed after a person became ill.

Symptoms and severity

Infection ranges from no symptoms to severe respiratory illness and encephalitis, an inflammation of the brain. Early symptoms can include fever, headache, muscle pain, vomiting and sore throat. Dizziness, unusual drowsiness, confusion or seizures can follow. Some people develop pneumonia or severe breathing difficulties. WHO reports that severe cases can progress to coma within 24–48 hours. Its 2026 notice gives an incubation period of 3–14 days, with rare reports of up to 45 days. Across reported outbreaks, 40–75% of identified cases have died. This range is not a prediction for an individual patient: it varies with detection and clinical management. The retrieved sources do not provide separate fatality estimates with and without treatment.

Treatment and vaccines

WHO's notice dated 2026-06-25 states that there are no licensed medicines or vaccines specific to Nipah infection. Severe cases need intensive supportive care, particularly for breathing problems and neurological complications. Supportive care treats the effects of illness rather than directly eliminating the virus. WHO notes that early supportive treatment can save lives. Laboratory testing is important because the first symptoms are not specific to Nipah and can resemble other illnesses. Isolation and contact tracing are also central to the response, protecting people around a suspected or confirmed case. WHO lists Nipah as a priority for accelerated development of medical countermeasures. This page does not establish whether any licensing status changed after the latest retrieved notice.

Where it occurs

WHO reports outbreaks since 1998 in Bangladesh, India, Malaysia, the Philippines and Singapore. Bangladesh experiences recurring outbreaks, often linked to the date palm sap season. A WHO notice from 2024 describes cases usually occurring between December and April. In India, Kerala has had repeated outbreaks since 2018, while West Bengal has also reported infection. Fruit bats that can host Nipah occur across a much wider area, including South and Southeast Asia and parts of Oceania. The presence of these bats does not by itself show that human cases are occurring locally. Risk assessment needs evidence about animal infection, food exposures, human illness and opportunities for close-contact transmission, rather than a map of bat distribution alone.

Recent history

Open Outbreak's supplied archive contains 10 Nipah events; that is an archive count, not the total number of outbreaks worldwide. Retrieved archive entries span Malaysia in 1999 through Bangladesh and India in 2025. WHO reported four confirmed fatal cases in Bangladesh between 2025-01-01 and 2025-08-29, and four confirmed cases including two deaths in Kerala between 2025-05-17 and 2025-07-12. Retrieved 2026 notices describe two confirmed cases in West Bengal, one in Bangladesh, and one in Kerala. The latest retrieved notice, dated 2026-06-25, reported no secondary cases among the Kerala case's monitored contacts as of 2026-06-18. These dated reports should not be read as cumulative worldwide totals or as proof that no later events occurred before 2026-11-22.

What to watch

Important warning signals include confirmed cases in new regions, repeated unexplained animal-to-human infections, and larger or longer chains of person-to-person spread. Human-to-human transmission is already known, so the concern is a change in its extent, not its first appearance. Clusters among family caregivers or health-care workers would warrant close investigation. Delayed recognition also matters because early symptoms are not distinctive and severe disease can develop quickly. WHO's Kerala notice highlights the unresolved source of infection and says additional cases cannot be excluded. Practical response signals include timely testing, effective isolation and contact monitoring. Vaccine licensing and availability would be important developments; the retrieved WHO sources report no licensed vaccine. They provide no evidence of a current treatment-resistance problem.

Updated